Direct-acting antiviral agents (DAA) for Hepatitis C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Direct-acting antiviral agents (DAA) for Hepatitis C, covering 2017-08-09 to 2017-08-09. Get the full timeline:
Most recent: Clinical Trial Update: Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients [NA]